ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 118 filers reported holding ALLAKOS INC in Q3 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $321,362 | -73.8% | 141,569 | -49.7% | 0.00% | -75.0% |
Q2 2023 | $1,227,828 | -48.1% | 281,612 | -47.0% | 0.00% | -60.0% |
Q1 2023 | $2,363,853 | +397.0% | 531,203 | +840.3% | 0.01% | +233.3% |
Q4 2022 | $475,663 | +66.9% | 56,492 | +21.4% | 0.00% | +50.0% |
Q3 2022 | $285,000 | -22.8% | 46,528 | -28.2% | 0.00% | -33.3% |
Q1 2022 | $369,000 | -46.8% | 64,805 | +696.9% | 0.00% | -62.5% |
Q2 2021 | $694,000 | -39.5% | 8,132 | -32.4% | 0.01% | -77.8% |
Q4 2019 | $1,147,000 | – | 12,027 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RiverVest Venture Management LLC | 4,887,932 | $29,914,000 | 34.73% |
Logos Global Management LP | 5,936,666 | $36,332,000 | 4.47% |
TCG Crossover Management, LLC | 1,643,500 | $10,058,000 | 3.02% |
Vivo Capital, LLC | 4,120,134 | $25,215,000 | 2.78% |
Ally Bridge Group (NY) LLC | 598,172 | $3,661,000 | 2.42% |
Frazier Life Sciences Management, L.P. | 4,792,000 | $29,327,000 | 2.26% |
NEA Management Company, LLC | 6,148,704 | $33,867,000 | 1.69% |
COMMODORE CAPITAL LP | 1,643,500 | $10,058,000 | 1.62% |
BVF INC/IL | 5,006,921 | $30,642,000 | 1.27% |
Deep Track Capital, LP | 4,518,575 | $27,654,000 | 1.27% |